Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome

George Q. Li, Ka H. Wong, Antony Kam, Xian Zhou, Eshaifol A. Omar, Ali Alqahtani, Kong M. Li, Valentina Razmovski-Naumovski, Kelvin Chan

    Research output: Chapter in Book / Conference PaperChapter

    Abstract

    Metabolic syndrome, previously known as syndrome X and insulin resistance syndrome, refers to a constellation of disorders including central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension. These risk factors have been linked to an increased probability of cardiovascular diseases and type 2 diabetes mellitus. The World Health Organization (WHO) estimates that by 2015, approximately 2.3 billion adults worldwide will be overweight, and more than 700 million adults will be obese (WHO 2006). Additionally, the global prevalence of type 2 diabetes will rise to 336 million by 2030 (International Diabetes Foundation 2009).
    Original languageEnglish
    Title of host publicationChronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions
    EditorsSashwati Roy, Debasis Bagchi, Siba P. Raychaudhuri
    Place of PublicationU.S.A.
    PublisherCRC Press
    Pages337-350
    Number of pages14
    ISBN (Electronic)9781439872154
    ISBN (Print)9781439872116
    DOIs
    Publication statusPublished - 2012

    Keywords

    • traditional Chinese medicine
    • metabolic syndrome

    Fingerprint

    Dive into the research topics of 'Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome'. Together they form a unique fingerprint.

    Cite this